ANTIMICROBIAL RESISTANCE
Why in News?
Ahead of the September 26 UN General Assembly High-Level Meeting on antimicrobial resistance (AMR), the World Health Organization (WHO) has released new guidelines on antibiotic pollution from manufacturing.
WHO’s TAKE
- The WHO warns that AMR, driven by antibiotic pollution, could threaten the effectiveness of antibiotics worldwide.
- AMR is a serious issue affecting healthcare globally.
- It leads to the creation of “superbugs”—bacteria that are resistant to common antibiotics.
- This situation is particularly challenging for patients with multiple health issues.
- In India, a recent survey by the Indian Council of Medical Research (ICMR) shows that AMR is increasing despite consistent monitoring efforts.
WHAT IS AMR?
- AMR occurs when bacteria and other microbes evolve to survive even when treated with antimicrobial drugs like antibiotics.
- This usually happens due to misuse or overuse of these drugs.
- When antibiotics are overused, it can lead to the development of superbugs.
- These are bacteria that do not respond to common treatments and can spread through hospitals, water, or sewage.
- This makes treating simple infections difficult, often requiring hospital admission and leading to more complex and costly treatments.
WHY IS AMR INCREASING?
- Individual Practices:
- Misuse of Antibiotics: Many people take antibiotics for viral infections like the flu, where they are ineffective. This misuse promotes resistance.
- Self-Medication: People often use antibiotics without a prescription or advice, increasing resistance risks.
- Healthcare Practices:
- Overuse in Hospitals: High rates of antibiotic prescriptions, including for non-infectious conditions, contribute to Broad-spectrum antibiotics, which target a wide range of bacteria, are often overused.
- Lack of Diagnostics:
- Empirical Prescribing: Doctors sometimes prescribe antibiotics based on symptoms rather than diagnostic tests, leading to inappropriate use of broad-spectrum drugs.
- Pharmaceutical Pollution:
- Manufacturing Waste: The WHO’s recent guidance highlights the role of antibiotic pollution from manufacturing. Pharmaceutical waste can contribute to AMR by promoting the development of resistant bacteria.
WHAT NEEDS TO BE DONE?
- Prevention:
- Hygiene and Sanitation: Implementing rigorous hygiene practices and improving sanitation can reduce infection rates.
- Vaccination: Encouraging vaccination can prevent infections and reduce the need for antibiotics.
- For example, pneumococcal and influenza vaccines can prevent diseases that may otherwise lead to antibiotic use.
- Education:
- Healthcare Professionals: Training doctors to use antibiotics appropriately, reserving strong antibiotics for severe infections, and relying on diagnostic tests can help reduce resistance.
- Public Awareness: Educating the public about the dangers of antibiotic misuse and the importance of completing prescribed courses.
- Regulation and Monitoring:
- Pharmaceutical Regulations: Strengthening regulations on pharmaceutical waste management to control antibiotic pollution and prevent the spread of resistant bacteria.
- Surveillance: Ongoing monitoring and research to track resistance patterns and adapt strategies accordingly.
- Research:
- Pathways of Resistance: Investigating how resistance develops from manufacturing processes and implementing regulations to address these issues.
Note: Connect with Vajirao & Reddy Institute to keep yourself updated with latest UPSC Current Affairs in English.
Note: We upload Current Affairs Except Sunday.
